Examining the Public Provision and Funding of PET-CT Imaging for Non-cancer Indications

Although PET-CTs are most commonly used for cancer-related indications, many jurisdictions have recognized their role in diagnosing neurological, cardiovascular, infectious and inflammatory pathologies. As a response to this, some jurisdictions have expanded the publicly funded indications for PET-CTs to include many non-cancer indications. The rapid synthesis seeks to address this by: identifying what non-cancer indications Canadian and OECD health systems have included in PET-CT packages of care; and what payment models are used to support its delivery.